MELIS, GIAN BENEDETTO
 Distribuzione geografica
Continente #
EU - Europa 340.154
NA - Nord America 29.326
AS - Asia 4.411
Continente sconosciuto - Info sul continente non disponibili 53
SA - Sud America 39
AF - Africa 37
OC - Oceania 27
Totale 374.047
Nazione #
IT - Italia 327.357
US - Stati Uniti d'America 29.094
UA - Ucraina 4.541
CN - Cina 3.160
DE - Germania 2.794
SE - Svezia 2.491
FI - Finlandia 1.018
GB - Regno Unito 908
SG - Singapore 906
RU - Federazione Russa 402
FR - Francia 388
CA - Canada 214
IN - India 140
BE - Belgio 55
EU - Europa 53
NL - Olanda 46
KR - Corea 43
VN - Vietnam 38
TR - Turchia 25
CH - Svizzera 23
BR - Brasile 22
ES - Italia 19
RO - Romania 18
AU - Australia 17
JP - Giappone 17
MU - Mauritius 16
CZ - Repubblica Ceca 14
MX - Messico 13
PL - Polonia 13
IE - Irlanda 12
TH - Thailandia 11
IL - Israele 10
NZ - Nuova Zelanda 10
BG - Bulgaria 9
IR - Iran 8
TW - Taiwan 8
ID - Indonesia 7
PT - Portogallo 7
ZA - Sudafrica 7
GE - Georgia 6
HK - Hong Kong 6
NO - Norvegia 6
PH - Filippine 6
AL - Albania 5
CL - Cile 5
GR - Grecia 5
CO - Colombia 4
DK - Danimarca 4
HR - Croazia 4
MY - Malesia 4
DZ - Algeria 3
EC - Ecuador 3
EG - Egitto 3
IS - Islanda 3
ME - Montenegro 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
JO - Giordania 2
LY - Libia 2
MN - Mongolia 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
TN - Tunisia 2
VE - Venezuela 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MG - Madagascar 1
OM - Oman 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
ZW - Zimbabwe 1
Totale 374.047
Città #
Cagliari 317.270
Uta 7.458
Fairfield 3.255
Chandler 2.829
Woodbridge 2.666
Jacksonville 2.451
Boardman 2.179
Ann Arbor 1.950
Ashburn 1.775
Houston 1.773
Wilmington 1.650
Seattle 1.313
Nyköping 1.255
Cambridge 1.060
Dearborn 750
Nanjing 747
Boston 477
Singapore 435
Helsinki 348
Beijing 347
Milan 289
Santa Clara 246
Shenyang 236
Nanchang 214
San Diego 185
Toronto 183
Verona 179
Hebei 166
Guangzhou 164
Changsha 162
Jiaxing 158
Shanghai 147
Tianjin 136
Los Angeles 124
Redwood City 112
Orange 102
Jinan 92
New York 88
Norwalk 81
Mountain View 79
Ningbo 78
Sassari 78
Auburn Hills 74
Washington 72
Rome 64
Saint Petersburg 63
Pune 62
London 59
Zhengzhou 55
Hefei 46
Kunming 41
Brussels 40
Taizhou 40
Dong Ket 32
Falls Church 31
Borås 29
Redmond 29
Millbury 25
Hangzhou 22
Wuhan 21
Seoul 20
Chicago 19
Columbus 19
Molise 17
Palermo 17
Pescara 17
Torino 15
Munich 14
San Mateo 14
Tappahannock 14
Treviso 14
Atlanta 13
Augusta 13
Kilburn 13
Mumbai 13
Fuzhou 12
Indiana 12
Padova 12
Settimo Torinese 12
Walnut 12
Bologna 11
Catania 11
Frankfurt am Main 11
Phoenix 11
Rockville 11
Quartu Sant'elena 10
Berlin 9
Chengdu 9
Chiswick 9
Dublin 9
Edinburgh 9
Paris 9
Alghero 8
Andover 8
Hounslow 8
Manchester 8
Messina 8
Prescot 8
Simi Valley 8
Brescia 7
Totale 356.566
Nome #
Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women 3.917
Pre-labor rupture of membranes (PROM) and modern metabolomics 3.793
PROM and labour effects on urinary metabolome: a pilot study 3.499
Overview of elagolix for the treatment of endometriosis 3.394
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation 3.281
Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach 3.280
Three-dimensional ultrasonography in the diagnosis of deep endometriosis 3.146
Review and meta-analysis of prospective randomized controlled trials (RCTs) comparing laparo-endoscopic single site and multiport laparoscopy in gynecologic operative procedures 3.065
Systemic therapy for the treatment of endometrial cancer 2.957
Vaginosi batterica: efficacia di un trattamento locale con un gel vaginale a base di una frazione batterica derivata da Propionibacterium acnes 2.923
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 2.879
The stimulation of the vaginal immune system with short-term administration of a vaginal gel containing fraction of Propionibacterium acnes, hyaluronic acid and polycarbophil is efficacious in vaginal infections dependent on disorders in the vaginal ecosystem 2.834
Olfactory performance in relation to sex and hormonal profile in humans 2.814
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health 2.782
Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta-analysis. 2.727
Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC) 2.626
Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in the rectosigmoid: systematic review and meta-analysis 2.595
Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature 2.584
Safe endobag morcellation in a single-port laparoscopy subtotal hysterectomy 2.566
Renal tumors in pregnancy: a systematic review 2.510
Endometrial ablation: first- vs. second-generation techniques 2.498
Studio epidemiologico sull’osteoporosi postmenopausale 2.493
Vilaprisan for treating uterine fibroids 2.448
Association between different morphological types and abnormal karyotypes in early pregnancy loss 2.419
Dismenorrea e endometriosi: una innovativa alternativa alla terapia farmacologica nel controllo del dolore 2.389
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.352
Sexual function in women with deep endometriosis: correlation with quality of life, intensity of pain, depression, anxiety, and body image 2.300
Changes of olfactory sensitivity related to sex and hormonal profile in humans 2.272
Clinical utility of elagolix as an oral treatment for women with uterine fibroids: A short report on the emerging efficacy data 2.242
Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study 2.205
Very low dose of flutamide in the treatment of hyperandrogenism 2.198
Studio osservazionale sul contraccettivo ormonale contenente estradiolo valerato e dienogest in formulazione quadrifasica: accettabilità, effetto favorevole sulla composizione corporea e sullo stato psicologico. 2.151
“CG Fem, PI 82, Vitamina E” per la terapia della menopausa: quali vantaggi per la sintomatologia neurovegetativa peri-post menopausale 2.119
Focusing on surgery results in infertile patients with deep endometriosis 2.083
Placental growth factor and preterm delivery 2.078
Rupture of renal angiomyolipoma in pregnancy 2.065
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment 1.981
Studio osservazionale sul contraccettivo ormonale a base di E2 1,5 mg/NOMAC 2,5 mg in formulazione monofasica 1.959
Deep Infiltrating Endometriosis: Comparison Between 2-Dimensional Ultrasonography (US), 3-Dimensional US, and Magnetic Resonance Imaging 1.957
Resistenza all’insulina nella PCOS e trattamento con inositolo e acido alfa-lipoico 1.953
Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome 1.938
Pregnancy Complications After Hysteroscopic Metroplasty: A Ten-Year Case-Control Study 1.916
Does the clinical information play a role in the magnetic resonance diagnostic confidence analysis of ovarian and deep endometriosis? 1.839
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE A BASE DI ESTRADIOLO (E2) 1.5 MG/NOMEGESTROLO (NOMAC) 2.5 MG IN FORMULAZIONE MONOFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SUI PARAMETRI ANTROPOMETRICI 1.837
Screening e diagnosi del Diabete Gestazionale in Sardegna: risultati a confronto. 1.816
SARCOPENIA: DIAGNOSI E PROSPETTIVE TERAPEUTICHE 1.806
Modificazioni dell’umore e del comportamento nel puerperio: quali fattori di rischio? 1.805
Il bi-test: solo screening di cromosomopatie fetali? 1.795
Correlazione fra anomalie morfologiche ecografiche e cariotipo patologico negli aborti precoci 1.779
Past, present and future ultrasonographic techniques for analyzing ovarian masses 1.777
The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 1.708
Progestins for symptomatic endometriosis: Results of clinical studies 1.681
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report 1.677
Comparison of laparoscopic intraoperative sentinel lymph node detection rates obtainable with vital dye or radioactive colloid in early stage endometrial cancer. A preliminary prospective trial 1.677
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol 1.663
Fattore di Crescita Placentare (PlGF): correlazioni con la funzione placentare 1.644
Modificazione dell'umore in gravidanza e nel post-partum: ruolo degli integratori 1.639
Diagnosi isteroscopica del tumore endometriale: nostra esperienza 1.600
ADDITIONAL VALUE OF CA-125 TO ULTRASOUND FOR PREDICTING SPECIFIC DIAGNOSIS OF BENIGN ADNEXAL CYSTS IN PREMENOPAUSAL 1.596
Tissue characterization using mean gray value analysis in deep infiltrating endometriosis 1.589
Diagnostic confidence analysis in the magnetic resonance imaging of ovarian and deep endometriosis: comparison with surgical results 1.586
CARATTERISTICHE DELLA "MESTRUAZIONE", DELLA PRESSIONE ARTERIOSA E DEI SINTOMI PSICOLOGICI IN CORSO DI SEI CICLI DI TRATTAMENTO CON IL CONTRACCETTIVO ORMONALE A BASE DI E2 1.5 MG/NOMAC 2.5 MG 1.525
Confronto tra diagnosi isteroscopica e istologica delle patologie endometriali maligne, nostra esperienza 1.510
Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. 1.469
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE CONTENENTE ESTRADIOLO VALERATO E DIENOGEST IN FORMULAZIONE QUADRIFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SULLO STATO PSICOLOGICO 1.463
Ultrasound features of rare primary malignant ovarian tumors 1.454
Endometriosis: the role of magnetic resonance imaging 1.451
Diagnostic performance of transvaginal power Doppler ultrasound for predicting malignancy of adnexsal masses in in symptomatic and asymptomatic women 1.446
OC24: The role of magnetic resonance imaging and transvaginal ultrasonography in patients with an adnexal mass and chronic pelvic pain or infertility 1.421
Dilated lateral ventricles and micrognathia by ultrasound exsamination in fetus with mosaic trisomy 9 1.401
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 1.394
LE ALTERAZIONI DELLA FASE OVULATORIA 1.389
La genetica dell'endometriosi 1.365
Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids 1.364
Dietary composition of pregnant women in south sardinia 1.305
Placental growth factor and placental perfusion 1.305
Low androgenization index in elderly women and elderly men with Alzheimer's disease 1.301
Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy 1.290
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.284
Alexithymia in women with deep endometriosis? A pilot study 1.260
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study 1.257
Ultrasound features of metastases in the ovary depending of the origin of the primary tumor 1.226
Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass 1.221
Pattern of bone markers during pregnancy and their changes after delivery. 1.219
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.215
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.184
Placental massive perivillous fibrin deposition after a previous uncomplicated term pregnancy: report of two cases. 1.182
Potentially beneficial cardiovascular effects of melatonin administration in women 1.182
Criteri diagnostici di PCOS: recenti evoluzioni 1.174
EZIOPATOGENESI DEI MIOMI UTERINI 1.172
Effect of desogestrel-containing oral contraceptived on vascular reactivity and catecholamine levels 1.164
B-mode and Power Doppler Ultrasound in Adnexsal Masses 1.148
Diagnosis of metabolic disorders in women with polycystic ovary syndrome 1.145
Obesity realated lipid profile and altered insulin incretion in adolescent with PCOS 1.126
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women 1.122
Intraoperative sentinel lymph node detection by vital dye through laparoscopy or laparotomy in early endometrial cancer 1.118
The treatment of polycystic ovary syndrome 1.106
Correlazioni tra composizione corporea ed età 1.084
null 1.083
Effects of melatonin on vascular reactivity, cathecolamine levels, and blood pressure in healthy men 1.071
Totale 190.298
Categoria #
all - tutte 531.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 531.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202059.127 0 0 0 0 24.312 15.143 9.998 2.632 1.610 1.216 1.932 2.284
2020/202183.774 3.384 2.778 3.589 20.749 18.396 10.152 9.566 4.890 1.453 3.435 3.317 2.065
2021/202221.003 2.026 1.912 976 1.605 2.219 1.676 1.714 1.144 1.730 1.563 2.131 2.307
2022/202332.914 3.274 3.477 3.426 2.326 2.319 2.863 1.216 6.240 2.374 1.667 2.477 1.255
2023/202441.278 2.652 2.451 2.455 3.441 4.144 6.068 5.935 2.207 2.275 3.189 3.483 2.978
2024/202534.371 5.661 9.439 8.792 7.401 3.078 0 0 0 0 0 0 0
Totale 374.884